Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition preparation and purification process of cycloartenyl ferulate

A technology of pineapple enol ferulate and pineapple alcohol ferulate, which is applied in the field of composition preparation and purification process of pineapple enol ferulate, and achieves fewer unit operations, higher yield and fewer steps. Effect

Active Publication Date: 2014-05-14
BEIJING CENTURY BIOCOM PHARMA TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The present invention solves the problem that there is no scheme to obtain cycloartenol ferulate from oryzanol in the current technical field. The disclosed process uses the current standard oryzanol medicine as raw material, and removes most of the oryzanol raw materials through modern separation and refining means. Non-cycloartenol ferulic acid ester components, so as to obtain cycloartenol ferulic acid ester with a purity of more than 80% (including 80%)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition preparation and purification process of cycloartenyl ferulate
  • Composition preparation and purification process of cycloartenyl ferulate
  • Composition preparation and purification process of cycloartenyl ferulate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Get 1 kg of oryzanol containing about 40% cycloarneol ferulate, heat and dissolve with 15 kg of ethyl acetate, leave it at room temperature until crystals are precipitated, filter, and dry. Repeat the above process for 10 times with the dried crystals to obtain a reference substance with a content of cycloartenol ferulic acid ester of more than 99%.

Embodiment 2

[0035] 1. Chromatographic conditions and system suitability test: octadecylsilane bonded silica gel is used as filler; methanol-acetonitrile (40:60) is used as mobile phase; flow rate is 1.5ml / min; detection wavelength is 327nm; sensitivity is 0.005 AUFS. The number of theoretical plates should not be less than 2000 according to the calculation.

[0036] 2. Preparation of the test solution: Accurately weigh 10 mg of the commercially available oryzanol raw material and 10 mg of the present invention, put them in a 10 ml measuring bottle, add water to dissolve and constant volume, and shake well to obtain the test solution.

[0037] 3. Determination: Accurately draw 10 μl of the test solution, inject it into a liquid chromatograph, record the chromatogram, and check the percentage content of each component by the area normalization method.

[0038] 4. Measurement results

[0039] Table 2 Measurement results

[0040]

[0041] Illustrate that technique of the present inventi...

Embodiment 3

[0043] prescription

[0044] 1000 bottles of freeze-dried powder of the present invention for injection (containing 18mg / bottle of the present invention):

[0045] Purified product of the present invention 18g

[0046] Macrogol 400 250g

[0047] Tween 80 250g

[0048] 10% Mannitol 6000g

[0049]

[0050] In the prescription, the raw material of the present invention is used as the main agent, Tween 80 is used as a solubilizing agent, polyethylene glycol 400 is used as a cosolvent, mannitol is used as a proppant, and water for injection is used as a freeze-drying solvent.

[0051] Preparation process

[0052] Take by weighing the purified product of the present invention, Tween-80, PEG-400, mannitol and 80% of the prescription amount of water for injection, stir to make it dissolve until the solution is clear, stir at room temperature for 20 minutes, and filter the mixture with a 0.45 μm microporous membrane Filtrate, add water for injection to the filtrate to the full ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for purifying cycloartenyl ferulate, which is realized by a repeated re-crystallization method. The purity of the cycloartenyl ferulate purified by the method is over 80 percent.

Description

[0001] This application is a divisional application of the patent for the invention of the composition preparation and purification process of cycloarpineol ferulic acid ester with the application number 2008101144052 filed by the applicant on June 2, 2008. technical field [0002] The invention discloses a purification process and preparation of cycloartenol ferulate. Further, the invention discloses a process for purifying cycloartenol ferulate from oryzanol raw materials by using recrystallization technology. Background technique [0003] With the gradual acceleration of the pace of life and work in modern society, the sub-health status of modern urbanites is not optimistic. According to statistics, patients with autonomic disorders, menopausal syndrome, primary dysmenorrhea, premenstrual tension, etc. due to autonomic dysfunction, lead to the imbalance of sympathetic and parasympathetic nerves, and the incidence of non-organic diseases is increasing year by year. trend. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J53/00
Inventor 郝守祝
Owner BEIJING CENTURY BIOCOM PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com